Details for Patent: 7,939,625
✉ Email this page to a colleague
Title: | Somatostatin analogues |
Abstract: | The invention provides cyclo[{4-(NH.sub.2--C.sub.2H.sub.4--NH--CO--O--)Pro}-Phg-DTrp-Lys-Tyr(4-B- enzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties. |
Inventor(s): | Albert; Rainer (Basel, CH), Bauer; Wilfried (Lampenberg, CH), Bodmer; David (Klingnau, CH), Bruns; Christian (Freiburg, DE), Felner; Ivo (Reinach, CH), Hellstern; Heribert (Heitersheim, DE), Lewis; Ian (Riehen, CH), Meisenbach; Mark (Durmenach, FR), Weckbecker; Gisbert (Biel-Benken, CH), Wietfeld; Bernhard (Efringen-Kirschen, DE) |
Assignee: | Novartis AG (Basel, CH) |
Filing Date: | Nov 05, 2008 |
Application Number: | 12/265,135 |
Claims: | 1. A method of inhibiting angiogenesis in a subject, wherein said method comprises administering an effective amount of a compound of formula ##STR00002## where one of the amino groups being optionally in protected form, or a salt or a complex thereof. 2. A method of treating pancreatic cancer in a subject, wherein said method comprises administering an effective amount of a compound of formula ##STR00003## where one of the amino groups being optionally in protected form, or a salt or a complex thereof. |